COVID-19 vaccine found to be 94.5% effective, says US biotech firm Moderna

The race to develop a #Covid19 vaccine picked up pace on Monday with US biotech firm Moderna announcing its candidate was 94.5% effective in interim analysis of its phase 3 trials, which involved more than 30,000 volunteers.